Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjögren syndrome-Reference-Cited by-同舟云学术

Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjögren syndrome

Published:2023-06-12 Issue:9 Volume:42 Page:2419-2425
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Pasoto Sandra Gofinet^ORCID,Borba Eduardo Ferreira,Formiga Francisco Fellipe Claudino,do Nascimento Pedrosa Tatiana,Aikawa Nadia Emi,de Siqueira Marilda Agudo Mendonça Teixeira,Capão Artur Silva Vidal,de Proença Adriana Coracini Tonacio,Fuller Ricardo,Yuki Emily Figueiredo Neves,Leon Elaine Pires,de Oliveira Martins Victor Adriano,Lopes Marta Heloisa,da Silva Duarte Alberto José,da Silva Clovis Artur Almeida,Bonfa Eloisa

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-023-06666-w.pdf

Reference29 articles.

1. Keilman LJ (2019) Seasonal influenza (flu). Nurs Clin N Am 54(2):227–243. https://doi.org/10.1016/j.cnur.2019.02.009

2. Jester BJ, Uyeki TM, Jernigan DB (2020) Fifty years of influenza A(H3N2) following the pandemic of 1968. Am J Public Health 110(5):669–676. https://doi.org/10.2105/AJPH.2019.305557

3. Mariette X, Criswell LA (2018) Primary Sjögren’s syndrome. N Engl J Med 378(10):931–939. https://doi.org/10.1056/NEJMcp1702514

4. Ramos-Casals M, Brito-Zerón P, Bombardieri S et al (2020) EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis 79(1):3–18. https://doi.org/10.1136/annrheumdis-2019-216114

5. Pasoto SG, Ribeiro AC, Bonfa E (2014) Update on infections and vaccinations in systemic lupus erythematosus and Sjögren’s syndrome. Curr Opin Rheumatol 26(5):528–537. https://doi.org/10.1097/BOR.0000000000000084